ASHG 2020 has moved online this year but there’s still plenty going on and lots of ways you can find out about how human genomics researchers are overcoming some of the big challenges i...

In this blog, Tao Jiang describes his work on the development of the structural variant (SV) caller cuteSV. Read on to find out how the cuteSV bioinformatics pipeline works, how it perfor...

Oxford, UK: Oxford Nanopore Technologies has raised £84.4M in new capital. The funding comes from existing investors and new investors, including International Holdings Company (IHC), R...

Oxford Nanopore, the Bill & Melinda Gates Foundation, US CDC, Microsoft and Illumina collaborate with the Africa Centres for Disease Control and Prevention (Africa CDC) to launch Afri...

LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19. LamPORE is designed to be performed on a desktop device, GridION, or a pa...

Accurate molecular diagnosis of cancer-causing germline variants enables increased screening, early detection, prevention, and optimal treatment, if cancer does arise in predisposed pat...

Guy has extensive experience in healthcare and technology investment and entrepreneurship. He was previously on the leadership team at Harel Insurance Investments and Financial Services, ...

In this blog, Filippo Martignano shares his research into copy number variation (CNV) analysis in cancer, from cell-free DNA samples, using shallow whole-genome sequencing. Read on to hea...

Scientists from the University of Oxford’s Nuffield Department of Medicine, Public Health England Porton Down (PHE), the University of Sheffield, Sheffield Teaching Hospitals NHS Foundati...

New Cas9 Sequencing Kit provides reagents for one-stop targeted sequencing, enabling scientists to cost-effectively sequence previously inaccessible target regions. Cas9 targeted sequ...

In this blog, Alba Sanchis-Juan, Javier Corral, and Belén de la Morena-Barrio describe their research into the genetic basis of thrombophilia, and how nanopore long sequencing reads were ...

In this blog, Katherine Dixon shares her team’s work on identifying structural variants in cancer genomes, and she explains why identifying them accurately is so important. Katherine ...

Ground-breaking British technology will initially provide hundreds of thousands of fast, accurate, low-cost COVID-19 tests under new agreement with the UK Government, with ...

The first telomere-to-telomere human chromosome was published in Nature this week — a landmark achievement for genomics researchers. Lead author Karen Miga, from the UC Santa Cruz Genomi...

Daniela Soto is a Ph.D. candidate in the Integrative Genetics and Genomics program at UC Davis, working in the Dennis Lab where she is using long-read sequencing technologies to unveil ...

LamPORE is a new assay, in advanced development at Oxford Nanopore. It is designed to detect the presence of SARS-CoV-2, the virus that causes COVID-19, in a saliva, swab or environmenta...

Company launches Q Line sequencing portfolio for users in regulated settings Oxford Nanopore today announced its pathway towards providing products for the diagnostics and other regulat...

London Calling this year took a very different format, going online for the first time ever. With over 5,500 people tuning in to see the action, either live or on-demand, it was a fantast...

End-to-end solution will enable mass/on-demand screening to support the re-opening of global economies. Abu Dhabi; June 09, 2020: Group 42 (G42), a leading AI and Cloud Computing compan...

In this blog, Beatriz Delgado Corrales, Óscar González Recio, and Mónica Gutiérrez Rivas describe their work on classifying rumen microbiomes, comparing long-read and short-read sequencin...

26th May 2020, Oxford, UK: Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital. The funding comes from new investors and existing shareholders in EMEA, US and Asia, a...

LamPORE is designed for use in both high-throughput labs or decentralised locations- Oxford Nanopore Technologies is in advanced development of a new generation of end-to-end test (assay...

Latest kit release provides 96 native barcodes for PCR-free sequencing, allowing higher numbers of samples to be run on a single flow cell - including for SARS-CoV-2 whole genome sequenci...

Please visit our updated COVID mini-site Oxford Nanopore is working with public health laboratories around the world, and researchers in related areas, to support the current COVID-19 pa...

From COVID-19 research and epidemiology to plant genomics, analysis of eDNA to whole genome sequencing, the applications of MinION Mk1C are now being thoroughly explored by the Nanopore C...